Supporting oncology professionals through education

The content on this site is intended for healthcare professionals only

Videos [2280]
News [5225]
Articles [128]
Editorials [4]
Conferences [157]
elearning [13]
TIVO 1 study shows tivozanib an option for renal cell carcinoma
Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA
TIVO 1 study shows tivozanib an option for renal cell carcinoma ( Dr Robert Motzer - Memorial Sloan Kettering Cancer Centre, New York, USA )
25 Feb 2013
A new oestrogen receptor protein target
Dr Jason Carroll – University of Cambridge, UK
A new oestrogen receptor protein target ( Dr Jason Carroll – University of Cambridge, UK )
16 Dec 2012
Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic...
Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA
Ponatinib for CML and Philadelphia chromosome-positive acute lymphoblastic leukaemia ( Dr Jorge Cortes - MD Anderson Cancer Center, Houston, TX, USA )
13 Dec 2012
Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell...
Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA
Quizartinib for FLT3-ITD positive AML after second-line chemo or stem cell transplant ( Dr Mark Levis - Johns Hopkins Medicine, Baltimore, USA )
13 Dec 2012
HDAC inhibitors sensitise triple-negative breast cancer cells to PARP...
Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA
HDAC inhibitors sensitise triple-negative breast cancer cells to PARP inhibition and cisplatin treatment ( Dr Kapil Bhalla - University of Kansas Cancer Center, Kansas City, USA )
6 Dec 2012
Targeted therapies for colorectal cancer
Dr Alberto Bardelli – IFOM – University of Turin-Medical School, Italy
Targeted therapies for colorectal cancer ( Dr Alberto Bardelli – IFOM – University of Turin-Medical School, Italy )
21 Nov 2012
Highlights from the 4th EUTROC meeting
Prof John Green – University of Liverpool, UK
Highlights from the 4th EUTROC meeting ( Prof John Green – University of Liverpool, UK )
15 Nov 2012
Interplay between pathologies of ovarian cancer and genomics
Prof David Huntsman – University of British Columbia, Vancouver, Canada
Interplay between pathologies of ovarian cancer and genomics ( Prof David Huntsman – University of British Columbia, Vancouver, Canada )
15 Nov 2012
Biology of molecular sub types in ovarian cancer
Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia
Biology of molecular sub types in ovarian cancer ( Prof David Bowtell – Peter MacCallum Cancer Centre, Melbourne, Australia )
15 Nov 2012
Early stage biomarkers in ovarian cancer
Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy
Early stage biomarkers in ovarian cancer ( Prof Angelo Paradiso – National Cancer Research Institute, Bari, Italy )
15 Nov 2012
Development of future cancer treatments
Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK
Development of future cancer treatments ( Dr Herbie Newell - Northern Institute for Cancer Research, Newcastle, UK )
14 Nov 2012
Advances in the treatment of colorectal cancer
Dr Patrick Johnston - Queens University, Belfast, UK
Advances in the treatment of colorectal cancer ( Dr Patrick Johnston - Queens University, Belfast, UK )
14 Nov 2012

More from ecancer

Register with ecancer to receive our newsletter

Register here

Explore patient resources at ecancerpatient

Visit site

Find out more about ecancer and the work we do

About ecancer

Support ecancer's work by making a donation